A groundbreaking discovery has unveiled a surprising molecular link between Parkinson’s disease and tuberculosis (TB), shedding light on a potential shared pathway that could revolutionize the treatment of both conditions. Central to this discovery is the LRRK2 protein (Leucine-rich repe